Targeted TDCS to Enhance Speech-Language Treatment Outcome in Persons With Chronic Post-Stroke Aphasia. (AphasiatDCS)
Stroke, Aphasia
About this trial
This is an interventional treatment trial for Stroke focused on measuring Stroke, Aphasia, brain stimulation, communication problems, speech and language therapy
Eligibility Criteria
Inclusion Criteria:
- aged 25-85
- must be greater than 1 year post-stroke
- must have a diagnosis of aphasia based on impaired performance on the Western Aphasia Battery-Revised, Boston Naming Test, or during discourse production
- must be left-hemisphere dominant as demonstrated by aphasia onset subsequent to left hemisphere damage
- must be stimulable for naming
Exclusion Criteria:
- comorbid neurological disease.
- damage to the anterior right hemisphere.
- significant mood disorder.
- substance/alcohol dependence or abuse within the past year
- presence of any implanted electrical device or contraindications to tDCS or MRI
- recent medical instability (within 4 weeks)
- pregnancy
Sites / Locations
- University of New Mexico Center for Brain Recovery and RepairRecruiting
Arms of the Study
Arm 1
Arm 2
Active Comparator
Sham Comparator
Experimental: Active cathodal tDCS + Speech-language training
Comparator: Placebo cathodal tDCS + Speech-language training
In this arm, 31 patients with stroke induced Aphasia will undergo 15 sessions of active tDCS (x 30 minutes of stimulation) combined with 1 hour simultaneous speech-language training on consecutive weekdays.
In this arm, 31 patients with stroke induced Aphasia will undergo 15 sessions of sham tDCS (x 30 minutes sham) combined with 1 hour simultaneous speech-language training on consecutive weekdays..